Conatus Pharmaceuticals Inc (NASDAQ:CNAT)

7.17
Real-Time Quote
 +0.095 / +1.34%
Today’s Change
5.06
Today|||52-Week Range
15.67
+11.09%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$110.7M

Company Description

Conatus Pharmaceuticals, Inc. operates as a biotechnology company, which engages in the development and commercialization of novel medicines to treat liver diseases. It develops lead compound, emricasan, for the treatment of patients in orphan populations with chronic liver disease and acute exacerbations of chronic liver disease. The company was founded by Alfred P. Spada, Jennifer Giottonini Cayer, Steven J. Mento and Charles J. Cashion on July 13, 2005 and is headquartered in San Diego, CA.

Contact Information

Conatus Pharmaceuticals, Inc.
16745 West Bernardo Drive
San Diego California 92127
P:(858) 376-2600
Investor Relations:
(858) 376-2637

Employees

Shareholders

Individual stakeholders49.24%
Other institutional12.41%
Mutual fund holders11.79%

Top Executives

Steven J. MentoPresident, Chief Executive Officer & Director
Charles J. CashionChief Financial Officer, Secretary & SVP-Finance
Alfred P. SpadaCSO, Senior Vice President-Research & Development
Gary Craig BurgessChief Medical Officer & SVP-Clinical Research
Daniel L. RipleySenior Director & Head-Corporate Development

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.